These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmaceutical R&D performance by firm size: approval success rates and economic returns. DiMasi JA Am J Ther; 2014; 21(1):26-34. PubMed ID: 23344103 [TBL] [Abstract][Full Text] [Related]
5. Does R&D pay? Cavalla D; Minhas R Drug Discov Today; 2010 Mar; 15(5-6):230-4. PubMed ID: 19931643 [TBL] [Abstract][Full Text] [Related]
6. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
7. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures. Grabowski H Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474 [TBL] [Abstract][Full Text] [Related]
9. A changing drug supply. Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432 [No Abstract] [Full Text] [Related]
10. Clinical research: outlook from industry. Echols R Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942 [No Abstract] [Full Text] [Related]
11. Prospects for productivity. Booth B; Zemmel R Nat Rev Drug Discov; 2004 May; 3(5):451-6. PubMed ID: 15136792 [No Abstract] [Full Text] [Related]
12. The productivity crisis in pharmaceutical R&D. Pammolli F; Magazzini L; Riccaboni M Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293 [TBL] [Abstract][Full Text] [Related]
13. What drives operational performance in clinical R&D? Ringel M; Martin L; Hawkins C; Panier V; Denslow M; Buck L; Schulze U Nat Rev Drug Discov; 2016 Mar; 15(3):155-6. PubMed ID: 26846158 [No Abstract] [Full Text] [Related]
14. Pharmaceutical R&D: the road to positive returns. David E; Tramontin T; Zemmel R Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471 [No Abstract] [Full Text] [Related]
15. Reviving an R&D pipeline: a step change in the Phase II success rate. Wu SS; Fernando K; Allerton C; Jansen KU; Vincent MS; Dolsten M Drug Discov Today; 2021 Feb; 26(2):308-314. PubMed ID: 33129994 [TBL] [Abstract][Full Text] [Related]
16. Stepping up to the plate. Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245 [No Abstract] [Full Text] [Related]
17. Japan unveils 5-year plan to boost clinical research. McCurry J Lancet; 2007 Apr; 369(9570):1333-6. PubMed ID: 17455378 [No Abstract] [Full Text] [Related]
18. Biotech R&D still reeling. Lawrence S Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460 [No Abstract] [Full Text] [Related]
19. Brand-name drug companies fail to meet R&D commitments. Kondro W CMAJ; 2006 Aug; 175(4):344. PubMed ID: 16908891 [No Abstract] [Full Text] [Related]
20. R&D efficiency of leading pharmaceutical companies - A 20-year analysis. Schuhmacher A; Wilisch L; Kuss M; Kandelbauer A; Hinder M; Gassmann O Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]